Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review

Journal of Cutaneous Medicine and Surgery
Patrick FlemingCharles W Lynde

Abstract

There are currently several reputable guidelines on the treatment of actinic keratosis (AK) from groups in Canada, the United Kingdom, and Europe. These recommendations, based on evidence or expert consensus, offer clinicians a variety of treatment options for the different clinical presentations of AKs. Although the guidelines are similar in some regards, variations exist in treatment options, duration, and strength of recommendation. Some guidelines also lack input on specific therapies and certain types of AK, such as hypertrophic or thin presentations. The purpose of this article is to review and compare guidelines published by Canadian, UK, and European groups for the management of AKs in patients.

References

Jan 1, 1996·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·W P ColemanS H Mandy
Mar 1, 1997·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·D D WitheilerR G Freemen
Aug 12, 2000·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·S E Chiarello
Dec 12, 2001·International Journal of Dermatology·J E WolfS Kang
Feb 13, 2003·Journal of the American Academy of Dermatology·David M PariserPaul S Yamauchi
Dec 28, 2006·Journal of the American Academy of Dermatology·Lasse R BraathenUNKNOWN International Society for Photodynamic Therapy in Dermatology
Dec 11, 2007·The British Journal of Dermatology·M VatveG Gupta
Mar 25, 2009·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Rolf-Markus SzeimiesDiamant Thaçi
May 7, 2009·International Journal of Dermatology·Deborah A AskewDavid Wilkinson
May 27, 2009·Journal of the American Academy of Dermatology·Lawrence AndersonJanelle Katsamas
Nov 6, 2010·Clinical Transplantation·Tanawat JirakulapornArkadiusz Z Dudek
Jul 9, 2011·Anais Brasileiros De Dermatologia·Janyana Marcela Doro Deonizio, Fabiane Andrade Mulinari-Brenner
Feb 22, 2012·The British Journal of Dermatology·K Togsverd-BoM Hædesdal
Mar 16, 2012·The New England Journal of Medicine·Mark LebwohlBrian Berman
Dec 19, 2012·Journal of the American Academy of Dermatology·Roger I Ceilley, Joseph L Jorizzo
May 1, 2015·Journal of Cutaneous Medicine and Surgery·Yves PoulinUNKNOWN Canadian non-Melanoma Skin Cancer Guidelines Committee
Aug 4, 2015·Journal of Dermatological Case Reports·Claudia CostaGiuseppe Monfrecola
Oct 10, 2015·Dermatology Research and Practice·Joslyn S KirbySara Ferguson
Oct 22, 2015·The New England Journal of Medicine·Andrew C ChenDiona L Damian
Jan 18, 2017·The British Journal of Dermatology·D de BerkerB R Hughes

❮ Previous
Next ❯

Citations

Apr 19, 2018·Dermatology : International Journal for Clinical and Investigative Dermatology·Larissa S MeierGünther F L Hofbauer
Jun 11, 2019·British Journal of Hospital Medicine·Amr SalamE Mary Wain
May 31, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·D NashanC Berking
Jul 11, 2020·Dermatologic Therapy·Elvira MoscarellaGiuseppe Argenziano
Dec 3, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·W G Philipp-DormstonK-M Thoms
Jul 25, 2021·The Annals of Pharmacotherapy·Diem-Phuong D DaoSteven R Feldman
Oct 26, 2021·The Journal of Investigative Dermatology·Lara CamilloPaola Savoia

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
contraception

Software Mentioned

Google Scholar

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.